CLINICAL_TRIALS
trial_result
· 2018-01-23
Clinical Trial Update: Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial comparing once-weekly semaglutide to placebo in drug-naïve type 2 diabetes patients; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2018-01-23